chr2-21006574-G-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000384.3(APOB):​c.10294C>G​(p.Gln3432Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00922 in 1,614,016 control chromosomes in the GnomAD database, including 93 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q3432R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0067 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0095 ( 91 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

6
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 2.30

Publications

21 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006468892).
BP6
Variant 2-21006574-G-C is Benign according to our data. Variant chr2-21006574-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 180279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.10294C>Gp.Gln3432Glu
missense
Exon 26 of 29NP_000375.3P04114

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.10294C>Gp.Gln3432Glu
missense
Exon 26 of 29ENSP00000233242.1P04114

Frequencies

GnomAD3 genomes
AF:
0.00665
AC:
1012
AN:
152136
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00195
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00485
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00933
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0106
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00723
AC:
1816
AN:
251196
AF XY:
0.00725
show subpopulations
Gnomad AFR exome
AF:
0.00185
Gnomad AMR exome
AF:
0.00474
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00994
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00948
AC:
13861
AN:
1461762
Hom.:
91
Cov.:
36
AF XY:
0.00916
AC XY:
6660
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33464
American (AMR)
AF:
0.00483
AC:
216
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00172
AC:
148
AN:
86254
European-Finnish (FIN)
AF:
0.00992
AC:
530
AN:
53410
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5766
European-Non Finnish (NFE)
AF:
0.0111
AC:
12356
AN:
1111930
Other (OTH)
AF:
0.00871
AC:
526
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
871
1742
2614
3485
4356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00665
AC:
1013
AN:
152254
Hom.:
2
Cov.:
33
AF XY:
0.00608
AC XY:
453
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00195
AC:
81
AN:
41560
American (AMR)
AF:
0.00484
AC:
74
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4824
European-Finnish (FIN)
AF:
0.00933
AC:
99
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0106
AC:
724
AN:
68006
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
54
107
161
214
268
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00945
Hom.:
6
Bravo
AF:
0.00624
TwinsUK
AF:
0.00971
AC:
36
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.0116
AC:
100
ExAC
AF:
0.00759
AC:
921
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00938
EpiControl
AF:
0.00948

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
5
Hypercholesterolemia, familial, 1 (5)
-
-
4
not specified (4)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
17
DANN
Uncertain
1.0
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.80
D
MetaRNN
Benign
0.0065
T
MetaSVM
Benign
-0.32
T
PhyloP100
2.3
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.98
N
REVEL
Uncertain
0.31
Sift
Benign
0.042
D
Sift4G
Uncertain
0.031
D
Vest4
0.16
MVP
0.84
MPC
0.049
ClinPred
0.021
T
GERP RS
5.7
gMVP
0.31
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042023; hg19: chr2-21229446; COSMIC: COSV99028656; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.